Researcher
S. Jay Olshansky
Last updated 2026-07-02· Last reviewed 2026-07-02· 1 min read
Reviewed by the Ultimate Longevity Bible editorial team. Educational reference — not medical advice. See disclaimer.
Contributions
- Quantitative demographic modelling of what disease-prevention actually yields for population life expectancy.
- Public advocacy for treating aging as an FDA-recognised indication.
- Foundational to the geroscience-hypothesis policy argument.
Style
Data-driven, publicly-vocal, and effective at translating academic findings for policy audiences.
Longevity relevance
The demographic case for geroscience: single-disease efforts have already delivered most of their gains; further progress requires addressing shared biology of aging.
- Maximum Lifespan vs Life Expectancy — Concept.
- Age Later — Nir Barzilai (2020) — Book.
- Gompertz Law of Mortality — Concept.
- Metformin — Intervention.
- Metformin and Cancer Prevention (secondary analyses) — Trial.
Related entries
Geroscience hypothesis, TAME trial, Nir Barzilai, Compression of morbidity.